MetaCap

BioAge Labs Insider Trades

NASDAQ: BIOAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.21-0.05 (-0.80%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
13 · $7.79M
Shares bought / sold
0 / 440.69K
Net activity
Net selling $7.8 million

BioAge Labs insider activity

Over the last 12 months, BioAge Labs insiders reported 36 transactions on SEC Form 4: 0 open-market purchases and 13 sales. Insiders bought $0 and sold $7.8 million worth of stock, for net insider selling of $7.8 million. The largest seller was Fortney Kristen, with $4.2 million in reported sales.

The most recent filing shows Barton Shane (Principal Accounting Officer) reporting a transaction in 4,290 shares at $10.85 on Jun 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BIOA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BIOA insider transactions

BioAge Labs insider transactions
DateInsiderTypeSharesValueFiling
Jun 30, 2026Barton ShanePrincipal Accounting OfficerSale20,216$509.18KForm 4
Jun 30, 2026Barton ShanePrincipal Accounting OfficerOption exercise7,861$34.43KForm 4
Jun 30, 2026Barton ShanePrincipal Accounting OfficerOption exercise4,065$17.48KForm 4
Jun 30, 2026Barton ShanePrincipal Accounting OfficerOption exercise4,000$33.56KForm 4
Jun 30, 2026Barton ShanePrincipal Accounting OfficerOption exercise4,290$46.55KForm 4
Jun 29, 2026Barton ShanePrincipal Accounting OfficerSale42,350$1.07MForm 4
Jun 29, 2026Barton ShanePrincipal Accounting OfficerOption exercise14,198$62.19KForm 4
Jun 29, 2026Barton ShanePrincipal Accounting OfficerOption exercise8,958$38.52KForm 4
Jun 29, 2026Barton ShanePrincipal Accounting OfficerOption exercise7,261$60.92KForm 4
Jun 29, 2026Barton ShanePrincipal Accounting OfficerOption exercise9,301$100.92KForm 4
Apr 23, 2026GOLDSTEIN DOV A MDChief Financial OfficerOption exercise3,542$15.51KForm 4
Apr 1, 2026RUBIN PAUL DChief Medical OfficerSale8,820$157.08KForm 4
Apr 1, 2026RUBIN PAUL DChief Medical OfficerOption exercise3,383$22.23KForm 4
Apr 1, 2026RUBIN PAUL DChief Medical OfficerOption exercise5,437$22.35KForm 4
Mar 2, 2026RUBIN PAUL DChief Medical OfficerSale7,433$150.89KForm 4
Mar 2, 2026RUBIN PAUL DChief Medical OfficerOption exercise2,000$13.14KForm 4
Mar 2, 2026RUBIN PAUL DChief Medical OfficerOption exercise5,433$22.33KForm 4
Mar 1, 2026GOLDSTEIN DOV A MDChief Financial OfficerOption exercise3,542$15.51KForm 4
Feb 2, 2026RUBIN PAUL DChief Medical OfficerSale7,433$139.37KForm 4
Feb 2, 2026RUBIN PAUL DChief Medical OfficerOption exercise2,000$13.14KForm 4
Feb 2, 2026RUBIN PAUL DChief Medical OfficerOption exercise5,433$22.33KForm 4
Feb 1, 2026GOLDSTEIN DOV A MDChief Financial OfficerOption exercise3,541$15.51KForm 4
Jan 16, 2026GOLDSTEIN DOV A MDChief Financial OfficerOption exercise3,542$15.51KForm 4
Jan 13, 2026Fortney KristenChief Executive OfficerSale233,107$4.22MForm 4
Jan 13, 2026GOLDSTEIN DOV A MDChief Financial OfficerSale1,923$40.54KForm 4
Jan 13, 2026GOLDSTEIN DOV A MDChief Financial OfficerSale11,663$239.55KForm 4
Jan 13, 2026GOLDSTEIN DOV A MDChief Financial OfficerSale4,440$86.37KForm 4
Jan 13, 2026GOLDSTEIN DOV A MDChief Financial OfficerSale8,974$165.37KForm 4
Jan 13, 2026GOLDSTEIN DOV A MDChief Financial OfficerOption exercise27,000$226.53KForm 4
Jan 2, 2026RUBIN PAUL DChief Medical OfficerSale7,433$95.49KForm 4
Jan 2, 2026RUBIN PAUL DChief Medical OfficerOption exercise2,000$13.14KForm 4
Jan 2, 2026RUBIN PAUL DChief Medical OfficerOption exercise5,433$22.33KForm 4
Dec 9, 2025RUBIN PAUL DChief Medical OfficerSale18,000$216.00KForm 4
Dec 9, 2025RUBIN PAUL DChief Medical OfficerOption exercise18,000$118.26KForm 4
Dec 4, 2025RUBIN PAUL DChief Medical OfficerSale68,897$701.91KForm 4
Dec 4, 2025RUBIN PAUL DChief Medical OfficerOption exercise68,897$283.17KForm 4
Oct 3, 2024Pande Vijay SatyanandDirectorBuy25,306$503.59KForm 4
Oct 2, 2024Pande Vijay SatyanandDirectorBuy67,096$1.32MForm 4
Oct 1, 2024Pande Vijay SatyanandDirectorBuy126,793$2.50MForm 4
Sep 27, 2024Barton ShanePrincipal Accounting OfficerBuy2,632$47.38KForm 4
Sep 27, 2024Hemrajani RekhaDirectorBuy3,000$54.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related